Stocks · Health care · Services-Commercial Physical & Biological Research

Incyte

INCY Clue Score72
United States Fiscal year ends December CIK 0000879169
112.79
+0.04%
Close, 9 Oct 2026 · USD

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close
112.79 on 9 Oct 2026
130 107 85 Oct 2025 Apr 2026 Oct 2026 13 Oct 2025 $84.73 14 Oct 2025 $85.96 15 Oct 2025 $88.15 16 Oct 2025 $87.31 17 Oct 2025 $87.57 20 Oct 2025 $86.17 21 Oct 2025 $87.30 22 Oct 2025 $88.06 23 Oct 2025 $89.31 24 Oct 2025 $91.28 27 Oct 2025 $93.08 28 Oct 2025 $91.65 29 Oct 2025 $90.18 30 Oct 2025 $92.59 31 Oct 2025 $93.48 3 Nov 2025 $101.57 4 Nov 2025 $102.92 5 Nov 2025 $105.70 6 Nov 2025 $105.20 7 Nov 2025 $105.98 10 Nov 2025 $105.98 11 Nov 2025 $108.16 12 Nov 2025 $108.26 13 Nov 2025 $105.41 14 Nov 2025 $104.15 17 Nov 2025 $104.17 18 Nov 2025 $103.89 19 Nov 2025 $101.32 20 Nov 2025 $101.76 21 Nov 2025 $102.06 24 Nov 2025 $106.24 25 Nov 2025 $105.55 26 Nov 2025 $105.65 28 Nov 2025 $104.46 1 Dec 2025 $102.04 2 Dec 2025 $101.44 3 Dec 2025 $101.50 4 Dec 2025 $100.46 5 Dec 2025 $102.52 8 Dec 2025 $96.70 9 Dec 2025 $95.16 10 Dec 2025 $95.17 11 Dec 2025 $96.10 12 Dec 2025 $95.41 15 Dec 2025 $98.64 16 Dec 2025 $97.03 17 Dec 2025 $97.63 18 Dec 2025 $97.31 19 Dec 2025 $102.69 22 Dec 2025 $100.71 23 Dec 2025 $100.91 24 Dec 2025 $100.44 26 Dec 2025 $100.11 29 Dec 2025 $99.29 30 Dec 2025 $98.91 31 Dec 2025 $98.77 2 Jan 2026 $101.42 5 Jan 2026 $101.79 6 Jan 2026 $106.66 7 Jan 2026 $110.57 8 Jan 2026 $105.92 9 Jan 2026 $106.87 12 Jan 2026 $106.33 13 Jan 2026 $103.43 14 Jan 2026 $105.95 15 Jan 2026 $105.24 16 Jan 2026 $106.21 20 Jan 2026 $102.62 21 Jan 2026 $104.67 22 Jan 2026 $105.06 23 Jan 2026 $101.99 26 Jan 2026 $102.58 27 Jan 2026 $103.47 28 Jan 2026 $101.18 29 Jan 2026 $101.08 30 Jan 2026 $100.07 2 Feb 2026 $102.67 3 Feb 2026 $100.92 4 Feb 2026 $102.60 5 Feb 2026 $102.76 6 Feb 2026 $108.39 9 Feb 2026 $109.03 10 Feb 2026 $100.05 11 Feb 2026 $98.84 12 Feb 2026 $100.75 13 Feb 2026 $101.10 17 Feb 2026 $101.16 18 Feb 2026 $102.99 19 Feb 2026 $101.73 20 Feb 2026 $101.32 23 Feb 2026 $100.85 24 Feb 2026 $101.05 25 Feb 2026 $99.98 26 Feb 2026 $100.09 27 Feb 2026 $101.27 2 Mar 2026 $100.04 3 Mar 2026 $98.07 4 Mar 2026 $98.86 5 Mar 2026 $97.33 6 Mar 2026 $95.94 9 Mar 2026 $97.10 10 Mar 2026 $96.02 11 Mar 2026 $94.66 12 Mar 2026 $92.03 13 Mar 2026 $92.54 16 Mar 2026 $93.00 17 Mar 2026 $94.22 18 Mar 2026 $92.24 19 Mar 2026 $92.95 20 Mar 2026 $90.78 23 Mar 2026 $90.45 24 Mar 2026 $90.62 25 Mar 2026 $92.23 26 Mar 2026 $92.26 27 Mar 2026 $90.30 30 Mar 2026 $90.33 31 Mar 2026 $94.12 1 Apr 2026 $94.30 2 Apr 2026 $95.93 6 Apr 2026 $94.86 7 Apr 2026 $93.69 8 Apr 2026 $95.89 9 Apr 2026 $96.96 10 Apr 2026 $96.07 13 Apr 2026 $95.55 14 Apr 2026 $97.69 15 Apr 2026 $97.10 16 Apr 2026 $95.32 17 Apr 2026 $97.82 20 Apr 2026 $96.92 21 Apr 2026 $96.22 22 Apr 2026 $96.74 23 Apr 2026 $95.47 24 Apr 2026 $94.65 27 Apr 2026 $95.72 28 Apr 2026 $97.74 29 Apr 2026 $99.10 30 Apr 2026 $95.27 1 May 2026 $96.91 4 May 2026 $97.14 5 May 2026 $97.47 6 May 2026 $99.85 7 May 2026 $97.77 8 May 2026 $98.56 11 May 2026 $100.32 12 May 2026 $99.13 13 May 2026 $98.82 14 May 2026 $97.63 15 May 2026 $95.31 18 May 2026 $95.19 19 May 2026 $95.60 20 May 2026 $97.08 21 May 2026 $97.41 22 May 2026 $97.16 26 May 2026 $97.10 27 May 2026 $97.34 28 May 2026 $97.50 29 May 2026 $96.74 1 Jun 2026 $95.59 2 Jun 2026 $92.24 3 Jun 2026 $97.98 4 Jun 2026 $101.24 5 Jun 2026 $102.38 8 Jun 2026 $100.64 9 Jun 2026 $103.23 10 Jun 2026 $105.39 11 Jun 2026 $107.83 12 Jun 2026 $108.53 15 Jun 2026 $101.98 16 Jun 2026 $99.75 17 Jun 2026 $98.99 18 Jun 2026 $98.22 22 Jun 2026 $103.66 23 Jun 2026 $104.40 24 Jun 2026 $108.46 25 Jun 2026 $107.53 26 Jun 2026 $113.75 29 Jun 2026 $114.66 30 Jun 2026 $113.36 1 Jul 2026 $113.81 2 Jul 2026 $116.86 6 Jul 2026 $115.62 7 Jul 2026 $118.05 8 Jul 2026 $117.26 9 Jul 2026 $118.52 10 Jul 2026 $116.71 13 Jul 2026 $114.23 14 Jul 2026 $114.88 15 Jul 2026 $115.09 16 Jul 2026 $116.65 17 Jul 2026 $117.25 20 Jul 2026 $115.65 21 Jul 2026 $117.39 22 Jul 2026 $115.79 23 Jul 2026 $116.69 24 Jul 2026 $117.67 27 Jul 2026 $118.87 28 Jul 2026 $129.93 29 Jul 2026 $127.10 30 Jul 2026 $122.99 31 Jul 2026 $119.52 3 Aug 2026 $118.43 4 Aug 2026 $120.60 5 Aug 2026 $119.80 6 Aug 2026 $118.38 7 Aug 2026 $120.56 10 Aug 2026 $121.55 11 Aug 2026 $121.07 12 Aug 2026 $120.77 13 Aug 2026 $120.52 14 Aug 2026 $120.16 17 Aug 2026 $123.50 18 Aug 2026 $123.47 19 Aug 2026 $128.47 20 Aug 2026 $127.22 21 Aug 2026 $127.81 24 Aug 2026 $127.98 25 Aug 2026 $129.72 26 Aug 2026 $128.12 27 Aug 2026 $127.74 28 Aug 2026 $124.37 31 Aug 2026 $123.22 1 Sep 2026 $125.01 2 Sep 2026 $128.83 3 Sep 2026 $128.00 4 Sep 2026 $126.75 8 Sep 2026 $124.40 9 Sep 2026 $126.01 10 Sep 2026 $123.28 11 Sep 2026 $121.47 14 Sep 2026 $122.19 15 Sep 2026 $121.74 16 Sep 2026 $124.75 17 Sep 2026 $127.62 18 Sep 2026 $125.31 21 Sep 2026 $124.65 22 Sep 2026 $126.93 23 Sep 2026 $124.64 24 Sep 2026 $124.44 25 Sep 2026 $123.89 28 Sep 2026 $124.82 29 Sep 2026 $123.20 30 Sep 2026 $121.35 1 Oct 2026 $117.14 2 Oct 2026 $115.30 5 Oct 2026 $114.13 6 Oct 2026 $112.73 7 Oct 2026 $113.44 8 Oct 2026 $112.75 9 Oct 2026 $112.79 Denton Sheila A. EVP & General Counsel Sold on a plan $23.58K 15 Oct 2025 · at $85.13 · 1.0% of stake Heeson Lee EVP, Head of Incyte Intl Sold on a plan $289.02K 3 Nov 2025 · at $94.02 · 9.5% of stake Denton Sheila A. EVP & General Counsel Sold on a plan $60.61K 4 Nov 2025 · at $101.36 · 2.2% of stake Stein Steven H EVP & Chief Medical Officer Sold on a plan $534.81K 5 Nov 2025 · at $102.20 · 4.8% of stake Hoppenot Herve Director Sold on a plan $19.77M 10 Nov 2025 · at $105.46 · 36.3% of stake Denton Sheila A. EVP & General Counsel Sold on a plan $29.01K 17 Nov 2025 · at $104.36 · 1.0% of stake Tray Thomas Principal Accounting Officer Sold on a plan $17.24K 21 Nov 2025 · at $102.00 · 0.7% of stake Tray Thomas Principal Accounting Officer Sold on a plan $61.80K 24 Nov 2025 · at $103.00 · 2.5% of stake Stein Steven H EVP & Chief Medical Officer Sold on a plan $263.47K 1 Dec 2025 · at $102.96 · 2.5% of stake Stein Steven H EVP & Chief Medical Officer Sold on a plan $2.06M 2 Dec 2025 · at $102.51 · 24.2% of stake Mayes Patrick A EVP & Chief Scientific Officer Sold on a plan $530.76K 10 Dec 2025 · at $95.58 · 8.4% of stake Mayes Patrick A EVP & Chief Scientific Officer Sold on a plan $24.21K 11 Dec 2025 · at $94.94 · 0.4% of stake Morrissey Michael James EVP, Head of Tech. Operations Sold on a plan $5.25M 16 Dec 2025 · at $97.29 · 62.9% of stake Morrissey Michael James EVP, Head of Tech. Operations Sold on a plan $420.45K 17 Dec 2025 · at $97.26 · 13.6% of stake Tray Thomas Principal Accounting Officer Sold on a plan $58.95K 18 Dec 2025 · at $98.25 · 2.5% of stake Tray Thomas Principal Accounting Officer Sold on a plan $277.40K 19 Dec 2025 · at $100.00 · 10.8% of stake Stein Steven H EVP & Chief Medical Officer Sold on a plan $1.59M 5 Jan 2026 · at $101.70 · 31.4% of stake Issa Mohamed Khairie EVP, Head of US Oncology Sold on a plan $1.18M 7 Jan 2026 · at $109.07 · 14.1% of stake CAGNONI PABLO J President, R&D Sold on a plan $1.88M 19 Feb 2026 · at $100.91 · 7.4% of stake CAGNONI PABLO J President, R&D Sold on a plan $1.76M 17 Mar 2026 · at $94.24 · 7.4% of stake CAGNONI PABLO J President, Global Head of R&D Sold on a plan $1.80M 17 Apr 2026 · at $96.50 · 6.6% of stake Clancy Paul J Director Sold on a plan $1.42M 19 May 2026 · at $94.93 · 38.7% of stake Tray Thomas Principal Accounting Officer Sold on a plan $199.66K 26 May 2026 · at $97.35 · 8.8% of stake Tray Thomas Principal Accounting Officer Sold on a plan $263.90K 4 Jun 2026 · at $100.00 · 11.1% of stake Stein Steven H CMO & Head of Late-Stage Dev. Sold on a plan $3.19M 15 Jul 2026 · at $113.05 · 52.0% of stake Issa Mohamed Khairie EVP, Head of U.S. Commercial Sold on a plan $125.71K 16 Jul 2026 · at $115.01 · 1.7% of stake Stein Steven H CMO & Head of Late-Stage Dev. Sold on a plan $215.35K 16 Jul 2026 · at $114.73 · 8.2% of stake CAGNONI PABLO J President, Global Head of R&D Sold on a plan $1.90M 31 Jul 2026 · at $119.70 · 6.9% of stake Mayes Patrick A EVP & Chief Scientific Officer Sold on a plan $5.01M 31 Jul 2026 · at $119.46 · 40.5% of stake Mayes Patrick A EVP & Chief Scientific Officer Sold on a plan $729.20K 3 Aug 2026 · at $120.43 · 9.0% of stake Mayes Patrick A EVP & Chief Scientific Officer Sold on a plan $273.65K 5 Aug 2026 · at $123.99 · 3.5% of stake CAGNONI PABLO J President, Global Head of R&D Sold on a plan $1.31M 5 Aug 2026 · at $122.69 · 4.9% of stake CAGNONI PABLO J President, Global Head of R&D Sold on a plan $1.30M 12 Aug 2026 · at $120.04 · 5.3% of stake CAGNONI PABLO J President, Global Head of R&D Sold on a plan $1.36M 19 Aug 2026 · at $125.56 · 5.6% of stake CAGNONI PABLO J President, Global Head of R&D Sold on a plan $2.80M 15 Sep 2026 · at $120.49 · 11.2% of stake
0 buys0 sales at will35 planned sales

Key numbers

Fiscal year 2025, ended 31 Dec 2025, as filed
Revenue
$5.14B
Net income
$1.29B
Free cash flow
$1.41B
Operating margin
29.5%
Net margin
25.0%
Return on equity
24.9%
Return on capital
4.8%
Debt to equity
3.70
Revenue growth, 1 yr
21.2%
Revenue growth, 5 yr
14.0% a year
EPS growth, 1 yr
4,173.3%

Revenue and net income

Fiscal years, as filed with the SEC · point at a year for the detail
2.7B -296M FY20 Fiscal year 2020 Revenue $2.67B Net income $295.70M Margin -11.1% 3B 949M FY21 Fiscal year 2021 Revenue $2.99B Net income $948.58M Margin 31.8% · growth +12.0% 3.4B 341M FY22 Fiscal year 2022 Revenue $3.39B Net income $340.66M Margin 10.0% · growth +13.7% 3.7B 598M FY23 Fiscal year 2023 Revenue $3.70B Net income $597.60M Margin 16.2% · growth +8.9% 4.2B 33M FY24 Fiscal year 2024 Revenue $4.24B Net income $32.62M Margin 0.8% · growth +14.8% 5.1B 1.3B FY25 Fiscal year 2025 Revenue $5.14B Net income $1.29B Margin 25.0% · growth +21.2%
RevenueNet incomeLoss

Latest insider transactions

From Form 4, most recent first
All of them →
DateInsiderTypeValueOf own stake
15 Sep 2026 CAGNONI PABLO J
President, Global Head of R&D
Sold on a plan $2.80M 11.2%
19 Aug 2026 CAGNONI PABLO J
President, Global Head of R&D
Sold on a plan $1.36M 5.6%
12 Aug 2026 CAGNONI PABLO J
President, Global Head of R&D
Sold on a plan $1.30M 5.3%
5 Aug 2026 CAGNONI PABLO J
President, Global Head of R&D
Sold on a plan $1.31M 4.9%
5 Aug 2026 Mayes Patrick A
EVP & Chief Scientific Officer
Sold on a plan $273.65K 3.5%
3 Aug 2026 Mayes Patrick A
EVP & Chief Scientific Officer
Sold on a plan $729.20K 9.0%